TG4010: A therapeutic vaccine against MUC1 expressing tumors

TG4010 is a therapeutic cancer vaccine based on a viral vector, a modified vaccinia of Ankara (MVA), expressing MUC1 as well as interleukine 2. Today the clinical development is focused on advanced non-small cell lung cancer in combination with first line chemotherapy. Potential biomarkers predictiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Limacher, Jean-Marc, Quoix, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429597/
https://www.ncbi.nlm.nih.gov/pubmed/22934285
http://dx.doi.org/10.4161/onci.19863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429597/
https://www.ncbi.nlm.nih.gov/pubmed/22934285
http://dx.doi.org/10.4161/onci.19863

Ejemplares similares